A Comparison of the Clinical Impact of Bleeding Measured by Two Different Classifications Among Patients With Acute Coronary Syndromes
Top Cited Papers
- 21 February 2006
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 47 (4) , 809-816
- https://doi.org/10.1016/j.jacc.2005.09.060
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Bleeding events with abciximab in acute coronary syndromes without early revascularization: an analysis of GUSTO IV–ACSAmerican Heart Journal, 2004
- Randomized, Placebo-Controlled Trial of Titrated Intravenous Lamifiban for Acute Coronary SyndromesCirculation, 2002
- TIME-DEPENDENT COVARIATES IN THE COX PROPORTIONAL-HAZARDS REGRESSION MODELAnnual Review of Public Health, 1999
- A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical CareNew England Journal of Medicine, 1999
- Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 1998
- A Comparison of Aspirin plus Tirofiban with Aspirin plus Heparin for Unstable AnginaNew England Journal of Medicine, 1998
- Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial InfarctionNew England Journal of Medicine, 1998
- A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary SyndromesNew England Journal of Medicine, 1996
- Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary AngioplastyNew England Journal of Medicine, 1994
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionNew England Journal of Medicine, 1993